Business Name: |
Shah Kamlesh B MD |
Contact Person: |
Kamlesh Shah, |
Address: |
2 Hillcrest Court, Willowbrook, Illinois 60527 |
Phone Number: |
(630) 789-1574 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Allergy & Asthma Specialists - Willowbrook, IL 60527 Koppula Samyukta MD - Willowbrook, IL 60527 Veselik Keith E MD - Willowbrook, IL 60527 Desai Dina R MD - Willowbrook, IL 60527 Murrey Susan S MD - Willowbrook, IL 60527 Staszkiewicz Andrzej MD - Willowbrook, IL 60527 Jain Madhu B MD - Willowbrook, IL 60527 Sun Ning MD - Willowbrook, IL 60527 Khawaja Wasim MD - Willowbrook, IL 60527 Kraig Richard MD - Willowbrook, IL 60527 Frese William MD - Willowbrook, IL 60527 Kuo May C MD - Willowbrook, IL 60527 Ayre Steven G MD - Willowbrook, IL 60527 Mcguire Mark E MD - Willowbrook, IL 60527 Raghu Ramadurai Md - Willowbrook, IL 60527 Se Chapter The Society Of Nuclear Medicine - Willowbrook, IL 60527 Thomas K Kron Md Ent Surgicalc - Willowbrook, IL 60527 Md Harsha Sud S C - Willowbrook, IL 60527 Akhtar Parvaiz Md - Willowbrook, IL 60527 Grzegorek Daniel J DO - Willowbrook, IL 60527 |
The company Shah Kamlesh B MD provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Shah Kamlesh B MD, and the business now earns $500.000 to $999.999 per annum.
Shah Kamlesh B MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Shah Kamlesh B MD, please call Kamlesh Shah, with the phone number (630) 789-1574 or visit its single location at 2 Hillcrest Court in Willowbrook, Illinois 60527.
The location of the single location can also be found using the coordinates 41.769662,-87.911659.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.